This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03610/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03610/identifier/pubchem-compound/
n6http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB03610/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB03610/identifier/drugbank/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03610
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB03610 n7:DB03610
dcterms:title
Alpha,Alpha,Alpha-Trifluoro-P-Cresol
adms:identifier
n9:67874 n10:46507301 n11:DB03610 n12:FCR
n3:IUPAC-Name
n4:271B588C-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5892-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5891-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B588E-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B588F-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5890-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B588A-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5888-363D-11E5-9242-09173F13E4C5 n4:271B588B-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5889-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5898-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5899-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5893-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5894-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5896-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5895-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5897-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B589E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B58A0-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B58A1-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B589D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B589C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B589F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B588D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B589A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B589B-363D-11E5-9242-09173F13E4C5